Subscribe to Entrepreneur for $5
Subscribe

Direct Hit

With direct public offerings, entrepreneurs can take financing into their own hands.

By
This story appears in the June 1997 issue of Entrepreneur. Subscribe »

Michael quinn's dilemma was a common one, but his solution was not.

After 10 years in business, Quinn wanted to go national. But his Hahnemann Laboratories Inc., a San Rafael, California, company that manufactures homeopathic medicines, needed to become a Food and Drug Administration-licensed pharmaceutical manufacturer if it was going to market its product across state lines. Where would Quinn get the capital to outfit a new facility?

Continue reading this article - and everything on Entrepreneur!

Become a member to get unlimited access and support the voices you want to hear more from. Get full access to Entrepreneur for just $5.

Get 3 months free with code zendesk

Presented by Zendesk

Champions of Customer Service zendesk

Entrepreneur Editors' Picks